Filing Details

Accession Number:
0001493152-24-033277
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-20 16:35:17
Reporting Period:
2024-08-15
Accepted Time:
2024-08-20 16:35:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1708599 Serina Therapeutics Inc. SER () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1329505 Gregory Bailey 601 Genome Way, Suite 2001
Huntsville AL 35806
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-15 6,400 $6.65 33,006 No 4 P Direct
Common Stock Acquisiton 2024-08-16 6,400 $7.31 39,406 No 4 P Direct
Common Stock Acquisiton 2024-08-19 6,400 $7.93 45,806 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.55 per share to a high of $7.94 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
  2. The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.12 per share to a high of $8.02 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
  3. The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.24 per share to a high of $8.57 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.